Zydus Wellness posts 30% profit growth in FY25, Q4 net sales up 17% YoY

For the quarter ended March 31, 2025, Zydus Wellness reported 17% year-on-year growth in net sales at ₹9,106 million, up from ₹7,780 million in Q4 FY24. Adjusted net profit after tax for the quarter was ₹1,719 million, an increase of 14.4% over the previous year. Quarterly EBITDA grew 17.1%, from ₹1,622 million to ₹1,900 million.

The company attributed its performance to continued marketing investments and the strong momentum of key brands including Nutralite, Glucon-D, Everyuth, and Nycil. The Food and Nutrition segment posted a quarterly growth of 15.4% and annual growth of 13% in FY25.

Following its 100% acquisition of Naturell (India) Private Limited, the newly integrated business is performing as expected.

Key brand performance during the year reflected continued market leadership across categories. The Sugar Free brand maintained its dominant position in the sugar substitute segment with a market share of 95.9%, reaffirming its leadership status. Similarly, Glucon-D retained its number one rank in its category, holding a market share of 58.8% at the MAT level.

While the overall Nutrition Drink category registered a decline of 2.1%* at the MAT level, Complan maintained its presence with a 4%* market share. Meanwhile, the company continued to strengthen and diversify its Nutralite product portfolio, building on innovation and distribution.

The Personal Care segment showed strong momentum with consistent double-digit growth. For Q4, the segment grew by 22.5%, while the full-year growth stood at 33.4%. Within this, Nycil remained the market leader in the prickly heat powder category with a share of 33.8%. Everyuth Scrub also sustained its leadership position, increasing its market share to 48.5%, a rise of 321.4 basis points compared to the same period last year.

The Everyuth brand further expanded into new segments with the launch of Sheet Masks in three variants—Golden Glow, Anti-Pollution, and Aloe Cucumber. Everyuth Peel Off continued to dominate its category with a 77.7%* share, reflecting a growth of 6.1 basis points. In the broader facial cleansing segment, Everyuth was ranked fifth with a 7.7%* market share.

Related Posts

CDSCO declares 159 drug samples as NSQs in June

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has announced a total of 159 drug samples tested across the country during the month of June, 2026, as Not of…

Donald Trump reveals 200% tariff plan for generic medicines. Will India exports be hit?

The decision could hit India hard, as it is the largest exporter of generic drugs to the US. US President Donald Trump has announced steep tariffs on imported generic medicines,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CDSCO declares 159 drug samples as NSQs in June

CDSCO declares 159 drug samples as NSQs in June

Donald Trump reveals 200% tariff plan for generic medicines. Will India exports be hit?

Donald Trump reveals 200% tariff plan for generic medicines. Will India exports be hit?

IIT Kanpur scientists’ research reveals how a promising vaccine booster switches on immune cells

IIT Kanpur scientists’ research reveals how a promising vaccine booster switches on immune cells

Government takes steps to strengthen primary healthcare services

Government takes steps to strengthen primary healthcare services

Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide

National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide